Pharmacokinetics (PK) and pharmacodynamics (PD) of rituximab administered by faster infusion in patients with previously untreated diffuse large B-cell (DLBCL) or follicular lymphoma (FL).
Michael Brewster
Employment or Leadership Position - Roche
Stock Ownership - Roche
Deborah Hurst
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Akiko Chai
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Edward James Lee
Research Funding - Genentech
Gargi H. Upadhyaya
Research Funding - Genentech
Shaker R. Dakhil
Research Funding - Genentech